Rich Daly

About the Author

Rich Daly

HFMA Senior Editor

Location: Downers Grove, IL

Rich Daly is senior editor, policy affairs with HFMA, based in Alabama. His healthcare policy and finance reporting experience includes staff writer positions with Modern Healthcare and Congressional Quarterly (both focused on healthcare regulatory and legislative developments); editor-in-chief of 340B Report (the only news outlet focused on daily policy, legal, and business developments in the 340B program); and serving as a content director for Sg2/Vizient Inc (producing reports on financial pain points and solutions for health systems). He previously covered daily news for HFMA and wrote features for Healthcare Financial Management magazine, where his recognitions included the Stephen Barr Award (the only individual achievement award) from the American Society of Business Publication Editors.

Latest Work

Medicare Advantage Rates, Policies Draw Insurer Praise

April 3—Medicare Advantage (MA) plans received an unexpected pay boost and generally beneficial policies in the final call letter and rules issued this week for 2019.

Rich Daly April 4, 2018

LTCH Pay Change to Cover Less than Half of Costs: Analysis

April 2—An ongoing Medicare payment change will cover less than half of the costs of care for long-term care hospital (LTCH) patients who are subject to it, according to a new analysis.

Rich Daly April 2, 2018

April 2-6 Policy Watch: National Opioid Summit to Highlight Challenges

March 29—Policymakers and healthcare providers will gather in Atlanta next week to identify effective approaches to an opioid crisis that appears to be worsening, according to new data.

Rich Daly March 29, 2018

Association Health Plans Advance Over Hospital Concerns

March 20—Congressional Republicans and small-business advocates this week rejected hospital concerns that proposed rules to allow a proliferation of association health plans (AHPs) would produce a range of problems.

Rich Daly March 21, 2018

340B Hospitals and Drugmakers Battle Over Transparency

March 16—Supporters and critics of the 340B discount drug program agree that more transparency is needed, but they remain sharply divided over who needs to be transparent and what such reporting should include.

Rich Daly March 16, 2018

March 19-23 Policy Watch: Push to Include ACA Marketplace Stabilization in Funding Bill

March 15—Healthcare leaders are renewing their push to include a stabilization measure in a must-pass federal funding bill that is required by the end of next week.

Rich Daly March 16, 2018

MACRA Improvements Coming, CMS Official Says

March 13—A series of regulatory changes are coming to the Medicare physician payment system this year, including an effort to ease quality-data reporting by hospital-employed physicians.

Rich Daly March 14, 2018

Where Is the Federal Government Going on Value-Based Pay?

March 9—Comments from the leader of federal healthcare policy disparaging the leading value-based payment models and hinting at new directions left some industry analysts confused, but others saw evidence of emerging models.  

Rich Daly March 9, 2018

March 12-16 Policy Watch: Congress to Review Drug Price Controls in Budget

March 8—The Trump administration has begun to put specifics behind its standing priority to reduce the cost of prescription drugs, including in its budget, which will be reviewed by a congressional panel next week.

Rich Daly March 8, 2018

Will CMS Allow Limits on Medicaid Eligibility?

March 7—Federal officials this week approved the third Medicaid waiver that requires work or other steps by beneficiaries but put off a decision on the key question of limiting eligibility.

Rich Daly March 8, 2018